Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 28, 2025Pediatric Pulmonology

Adjunctive Effects of Pediatric Tuina on Symptoms, Inflammation, and Pulmonary Function in Children With Severe Pneumonia: A Randomized Controlled Trial

View Full Paper
Ask AI
Bookmark
Share

Authors

THTing HeYCYing ChenHWHuiqing Wen

Discussion

Loading...

Member takes

Overview

Randomized controlled trial shows adjunctive tuina enhances pulmonary function and reduces inflammation in children with pneumonia, implying its potential as a complementary treatment.

Key Points

  • Tuina therapy significantly improved pulmonary function indicators in children with severe pneumonia.
  • Children receiving Tuina therapy experienced reduced hospitalization duration and lower inflammation levels.
  • The randomized controlled trial assessed symptom improvement and safety of Tuina versus standard treatment.
  • No serious adverse reactions occurred, supporting tuina as a complementary treatment option for pediatric pneumonia.

Cite This Study

He et al. (2025) studied this question.

synapsesocial.com/papers/6928f113a65b730b9ea79e1ahttps://doi.org/10.1002/ppul.71404
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Caregivers’ motivations for using pediatric Tuina for recurrent respiratory tract infections in young children in Southern China: a qualitative study2026
  2. 2Systematic Review and Meta-Analysis of Tuina as an Adjuvant Therapy for Functional Constipation in Children2026
  3. 3Pediatric tuina treatment for spleen deficiency diarrhea regulated through the skin-brain-gut axis and mast cell degranulation2024 · 5 citations
  4. 4Tuina for Chronic Non-specific Low Back Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials2026 · 1 citations
  5. 51170 Parent-Administered Pediatric Tuina for Sleep Disturbance in Early School-Aged Children with ADHD: An Exploratory Randomized Controlled Trial2026